US equities
|
MU
$1,038.36
▼-4.56%
NVDA
$230.35
▼-3.00%
SNDK
$1,607.28
▼-5.03%
AMD
$617.90
▼-4.33%
INTC
$106.01
▼-6.29%
SPCX
$161.90
▼-3.40%
META
$716.02
▼-0.73%
PLTR
$196.05
▲+1.00%
MU
$1,038.36
▼-4.56%
NVDA
$230.35
▼-3.00%
SNDK
$1,607.28
▼-5.03%
AMD
$617.90
▼-4.33%
INTC
$106.01
▼-6.29%
SPCX
$161.90
▼-3.40%
META
$716.02
▼-0.73%
PLTR
$196.05
▲+1.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Kenneth Hillan
Recent news which mentions Kenneth Hillan
23andMe is getting $50M from GSK to extend their research partnership
January 18, 2022
Tags
Pharmaceuticals
Biotech
Kenneth Hillan
From
Business Journals